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Viability Dye eFluor 660 -Thermo Fischer Scientific) used to exclude dead cells in all experiments. Detailed antibody information can be found in Dataset S1. Surface staining was performed in FACS Buffer (1x PBS, 1 mM EDTA, 25 mM HEPES pH 7.0, 1% FBS) at room temperature for 30 min. For cytokine expression analysis, cells were stimulated with 0.2 μM PMA (Sigma) and 1 μM Ionomycin (Sigma) in RPMI containing 10% FBS and protein transport inhibitor cocktail (eBioscience) for 4 hours. For intracellular staining of cytokines and transcription factors, cells were stained with surface markers, fixed in Fix/Perm buffer (eBioscience) for 30 min, washed in permeabilization buffer (eBioscience) twice, then intracellular factors were stained in permeabilization buffer for 30 min at room temperature. The negative thresholds were set using fluorescence minus one (FMO) labeled cells from participants with (trisomy 21, T21) and without Down syndrome (euploid controls, D21). Events were acquired using ZE5 Cell Analyzer (formerly Yeti, Bio-Rad) and data analysis was performed on FlowJo (Tree Star). For tSNE and FlowSOM plots, 10,000 cells were exported from FlowJo as .fcs files, uploaded in Cy3 software (Matlab based) and arcsinh cofactors were subsequently applied to every channel. The newly generated .fcs files were then uploaded into Rstudio and analyzed by tSNE and FlowSOM. A merged tSNE plot was generated (mapping 4,000 scholastically selected T cells from DS and T21 of all samples) in conjunction with FlowSOM where all T cells from DS and T21 of all samples were displayed.
In vitro assays
For in vitro suppression assays, fresh blood (40 mL) was processed as described above. CD4+ Tconv (CD14-CD19-CD8-CD4+ CD25low CD127high), CD4+ Treg (CD14-CD19-CD8-CD4+ CD25high CD127low) and CD8+ (CD14-CD19-CD8+ CD4-CD25-CD127-) T cells were purified from fresh PBMCs obtained by ficoll gradient centrifugation using a MoFlo XDP 4 70 (Beckman Coulter, Inc) cell sorter. Cells were counted with an automated cell counter (Countess II -Thermo Fisher Scientific). CD4+ Tconv and CD8+ T cells were used as responder cells and labeled with 5 mM CellTrace Violet (Life Technology) for 8 minutes at 37°C.
Responder effector cells (1x10 4 ) and different amounts of CD4+ Tregs (1:8 -1:1 Treg:Teff ratio) were cultured on 96-well round-bottom plates pre-coated with 0.5 mg/ml anti-CD3 (Invitrogen) in 1x PBS for activation. 1mg/ml anti-CD28 (Invitrogen) was then added for T cell activation, in 100 µL RPMI-1640 (Corning, Fisher Scientific) supplemented with 10% fetal bovine serum (Gibco, Thermo Fisher Scientific), 10 mM L-glutamine (Gibco, Thermo Fisher Scientific), 1x nonessential amino acids, 0.5x penicillin/ streptomycin and 1x sodium pyruvate (Corning, Fisher Scientific) for 5 days at 37°C. After 5 days, cocultures were stained with Fixable Viability Dye eFluor 660, αCD4, αCD8, αCD127, αCD25, αGZMB, αIFN-γ and αTNF-α. Briefly, cells were acquired on a ZE5 Cell Analyzer (formerly YETI) Propel Labs flow cytometer, and the division index of responder cells was analyzed using FlowJo based on the division of CellTrace Violet.
Suppression was then calculated as previously described (1) with the formula % Suppression = 100-(DITreg/DICtrl) x 100% (DITreg stands for the division index of responder cells with Tregs, and DICtrl stands for the division index of responder cells activated without Tregs).
RNAseq
For RNAseq of white blodo cells (WBCs), blood samples were immediately processed using a previously described protocol (2) and WBCs were cryopreserved in CryoStor CS10 Freezing Media (#210102) at ~10x10 6 cells/mL. WBCs were thawed quickly at 37°C and immediately spiked into 9 mL of complete RPMI media then centrifuged at 500 g for 5 min and media removed. Cells were resuspended in 600 µL RLT Plus (Qiagen) and Beta-mercaptoethanol (BME) lysis buffer (10 µL BME:1 mL RLT Plus). RNA was extracted using the AllPrep 5 DNA/RNA/Protein Mini Kit according to manufacturer's instructions (Qiagen, 80004). RNA quality was determined by Agilent 2200 TapeStation and quantified by Qubit (Life Technologies). Samples were sent to Novogene for stranded library prep and 2x150 paired-end sequencing (Illumina). RNAseq of T cells was previously described (2) . Bioinformatics analysis of RNAseq data was performed as described in our previous publication (2) . RNAseq data has been deposited in the Gene Expression Omnibus (GEO) under accession numbers GSE128622 for the WBC data and GSE84531 for the T cell data.
Mass cytometry antibody staining and data acquisition
Whole blood was collected into BD Vacutainer® K2 EDTA tubes (BD, 366643). For IFN stimulations, 0.5 mL of whole blood was treated with 10,000 U/mL of IFNa-2a (PBL #11100-1)
for 30 min at 37°C in 5% CO2, and processed for mass cytometry analyses using a protocol adapted from previous studies (3). Samples underwent red blood cell (RBC) lysis and fixation (BD Biosciences #558049), were then washed in 1x PBS (Rockland #MB-008) and Cell Staining Buffer (CSB, Fluidigm #201068), and then stored at -80°C in CSB. For staining, samples were quick-thawed at 37°C, washed in CSB, barcoded according to Fluidigm's Cell-ID 20-Plex Pd Barcoding Kit (#PRD023), then combined prior to staining. Extracellular staining with antibodies was done in CSB, then simultaneous detection of intracellular phospho-epitopes was accomplished using BD Pharmingen's Transcription Factor Phospho Buffer Set (#563239).
Barcoded and stained cells were labeled with Cell-ID Intercalator-Ir (Fluidigm, #201192A), then analyzed on a Helios instrument (Fluidigm) with antibody-metal conjugates listed in Dataset S1.
Mass cytometry data was pre-processed and normalized within and between batches via polystyrene beads embedded with lanthanides as previously described (4) 
